Position in AVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,984,433
+$3,091,970 QoQ
Shares Held
323,833
+67.2% QoQ
Ownership
0.604%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 126 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVTX Over Time
Shares Held
Position Value (USD)
Derivatives in AVTX
reported options exposure · as of Jun 30, 2026CallValue
$2,080,848
CallShares
112,600
PutValue
$255,024
PutShares
13,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. AVTX ranks #127 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in AVTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,080,848 | 112,600 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $255,024 | 13,800 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $5,984,433 | 323,833 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $997,324 | 66,800 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $2,892,463 | 193,735 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,617,955 | 419,491 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $138,539 | 10,900 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $6,122,012 | 481,669 | Shares | Defined | 2025-11-14 | |
| 2022-06-30 | $44,486 | 88,974 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $21,139 | 29,159 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $18,019 | 10,600 | Put | Defined | 2022-02-14 | |
| 2021-12-31 | $106,976 | 62,928 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $67,926 | 31,159 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $57,551 | 26,400 | Put | Defined | 2021-11-15 | |
| 2021-06-30 CERC | — | 24,264 | Shares | Defined | 2021-08-16 | |
| 2021-06-30 CERC | — | 21,600 | Put | Defined | 2021-08-16 | |
| 2021-03-31 CERC | — | 11,300 | Put | Defined | 2021-05-21 | |
| 2020-09-30 CERC | — | 14,219 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 CERC | — | 19,501 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 CERC | — | 32,759 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||